Mid-term hemodynamic and functional results after transcatheter mitral valve leaflet repair with the new PASCAL device.

Sebastian BarthMartina B HautmannEleni ArvanitiJan KikecSebastian KerberMichael ZacherPhilipp HalbfassPatrick RanoschLukas LehmkuhlBorek FoldynaUlrich LüsebrinkKarsten Hamm

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2020)

MR reduction of severe MR with the PASCAL device is feasible and safe regardless of etiologies. Mid-term follow-up at 5 months showed a sustained MR reduction, improvement of exercise capacity, quality of life, proBNP levels and hemodynamics regarding pulmonary capillary wedge pressure and right atrial pressure.

Keyphrases

mitral valve
left atrial
contrast enhanced
magnetic resonance
pulmonary hypertension
left ventricular
high intensity
atrial fibrillation
magnetic resonance imaging
physical activity
early onset
resistance training
computed tomography
body composition